SCHEMBL4560374

SCHEMBL4560374

CCCO[SiH](CCCOC(=O)C(C)(C)Br)OCCC

nearest known ligand 0.32

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
ATM Q13315 1/20 0.31
TSHR P16473 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
NAAA Q02083 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1968072 0.83 NAAA (0.33) ALDH1A1TSHRNAAA
SCHEMBL6514015 0.79 FAAH (0.32)
SCHEMBL649873 0.79 ALDH1A1 (0.52) ALDH1A1ATMTSHRTDP1L3MBTL1
SCHEMBL2332385 0.78 ALDH1A1 (0.42) ALDH1A1TSHRTDP1
SCHEMBL3344608 0.78 ALDH1A1 (0.57) ALDH1A1ATMTSHRNAAA
SCHEMBL11457160 0.77 NAAA (0.50) ALDH1A1TSHRNAAA
SCHEMBL16093069 0.77 POLB (0.31) ALDH1A1
SCHEMBL37083 0.76 POLB (0.39) ALDH1A1TSHRTDP1NAAA
SCHEMBL1803764 0.76 POLB (0.39) ALDH1A1ATMTSHRTDP1L3MBTL1
SCHEMBL650595 0.75 NAAA (0.53) ALDH1A1TSHRNAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090098057-A1 SILICA-CORED CARRIER PARTICLE QUANTUM MEDICAL IMAGING, L.L.C. 2009-04-16 US disclosed
US-6627314-B2 Polymerizing free radically polymerizable (co)monomers in presence of an initiation system; polymerizing one or more second radically polymerizable comonomers on the tethered polymer chain to form an tethered copolymer chain CARNEGIE MELLON UNIVERSITY 2003-09-30 US disclosed
US-20020106513-A1 Preparation of nanocomposite structures by controlled polymerization CARNEGIE MELLON UNIVERSITY 2002-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090098057-A1 SILICA-CORED CARRIER PARTICLE MSN, CD44, SND1 ALDH1A1 4020/4885ATM 3686/4885TSHR 2713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.